论文部分内容阅读
晚期非小细胞肺癌(NSCLC)尤其是多程治疗后的患者免疫功能低下,对化疗反应不敏感,甚至耐药,降低了临床疗效[1]。临床研究表明,艾迪注射液联合放化疗,能增强患者机体免疫力,具有减毒增效的作用[2-3]。我们应用艾迪注射液联合化疗治疗39例晚期NSCLC,通过观察治疗前后外周
Patients with advanced non-small cell lung cancer (NSCLC), especially after multiple courses of treatment, are immunocompromised and are refractory to chemotherapy and even resistant to chemotherapy, reducing their clinical efficacy [1]. Clinical studies have shown that Aidi injection combined with radiotherapy and chemotherapy, can enhance the patient’s immune system, with attenuated synergy [2-3]. We use Aidi injection combined with chemotherapy in the treatment of 39 cases of advanced NSCLC, by observing the treatment before and after the peripheral